简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
07515.HK
Csop Nikkei 225 Daily (-2x) Inverse Product (07515.HK) Rises 1.49% in Morning Trade, Turnover at HKD 5.7138 Million
Tags:
Csop Nikkei 225 Daily (-2x) Inverse Product
ETF
07515.HK
2026-06-11
Csop Nikkei 225 Daily (-2x) Inverse Product(07515.HK) Rose 2.56% in Morning Trading with an Turnover of HK$ 4.7187 Million
Tags:
ETF
Csop Nikkei 225 Daily (-2x) Inverse Product
07515.HK
2026-06-10
Csop Nikkei 225 Daily (-2x) Inverse Product(07515.HK) fell 2.92% intraday at an average price of HK$15.129
Tags:
Csop Nikkei 225 Daily (-2x) Inverse Product
07515.HK
ETF
2026-06-09
Csop Nikkei 225 Daily (-2x) Inverse Product(07515.HK) Surges Over 7% in Early Trading, Turnover Hits HK$15.0733 Million
Tags:
Csop Nikkei 225 Daily (-2x) Inverse Product
07515.HK
ETF
2026-06-08
CSOP Nikkei 225 Daily (-2x) Inverse Product (07515.HK) Falls 2.01%, Down Over 43% YTD
Tags:
Csop Nikkei 225 Daily (-2x) Inverse Product
07515.HK
ETF
2026-05-13
Csop Nikkei 225 Daily (-2x) Inverse Product(07515.HK) Rises 0.89%, Intraday Turnover Rate at 0.81%
Tags:
Csop Nikkei 225 Daily (-2x) Inverse Product
07515.HK
ETF
2026-05-11
Csop Nikkei 225 Daily (-2x) Inverse Product(07515.HK) Rises 1.15%, With AUM of Approximately HK$231 Million
Tags:
Csop Nikkei 225 Daily (-2x) Inverse Product
07515.HK
ETF
2026-04-28
Featured News
Finance
China Longyuan Power (00916.HK): Implementation of 2025 Equity Distribution, Final Dividend of RMB 0.625 per 10 Shares
Finance
Shenwan Hongyuan (06806.HK): Subsidiary’s RMB 3.6 Billion Corporate Bonds Listed on Shenzhen Stock Exchange
Finance
New Focus (00360.HK): Appointment of Hord Capital as Independent Financial Adviser
Finance
China Everbright Greentech (01257.HK): Entered Framework Agreements for Hazardous Waste Disposal Services Covering 2026 to 2028
Finance
Muyuan Co., Ltd. (02714.HK): Completes Corporate Name Change
Finance
CGII HLDGS (01940.HK): Completion of Loan Assignment
Finance
Guofu Hydrogen Energy (02582.HK): H-share Full Circulation Granted Listing Approval by HKEX
Finance
Wise Wealth Resources Investment (00007.HK): Appointment of Hao Xiaohui as Executive Director and Co-Chairman, Xu Shiping Re-designated as Co-Chairman
Finance
Fosun Pharma (02196.HK): Controlled Subsidiary’s HLX3902 Injection Obtains Clinical Trial Approval
Finance
Xunhe Group (01591.HK): Expected Annual Loss to Widen to HK$13 Million – HK$16 Million
Scan QR Code
Download App